Antibiotic susceptibility patterns of Vibrio cholerae isolates

Journal of the Nepal Medical Association

Volumn 49, Issue 3, 2010, Pages 232-236

  Shrestha, Sirjana Devi ^a,b   Malla, S ^a   Adhikari, B R ^a   Shakya, G ^a   Basnyat, S R ^b   Sharma, S ^a  

^a National Public Health Laboratory   (Nepal)

^b TRIBHUVAN UNIVERSITY   (Nepal)

Author keywords

Antibiotics; Susceptibility; Vibrio cholera

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; FURAZOLIDONE; NALIDIXIC ACID; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CHOLERA; CONTROLLED STUDY; DIARRHEA; FECES CULTURE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MOUSE; MULTIDRUG RESISTANCE; NEPAL; NONHUMAN; OBSERVATIONAL STUDY; SCHOOL CHILD; SEASONAL VARIATION; STRAIN IDENTIFICATION; VIBRIO CHOLERAE; ADOLESCENT; DRUG EFFECT; FECES; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, BACTERIAL; FECES; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; VIBRIO CHOLERAE;

EID: 84856367493     PISSN: 00282715     EISSN: None     Source Type: Journal    
DOI: 10.31729/jnma.95     Document Type: Article

References (25)

1. Rabbani HG, Greenough WB. Food as a Vehicle of Transmission of Cholera. Clinical Sciences Division, ICDDR, B: Centre for Health and Population Research. Journal of Diarrhoeal Diseases. 2002
2. Murray PR, Baron EJ. Manual of Clinical Microbiology. 9th ed. ASM Press; 2007.
3. Sherchand JB, Larsson S, Shrestha MP. Intestinal parasites in children and adults with and without abdominal discomfort from the Kathmandu area of Nepal. Trop Gastroenterol. 1996;17:15-22.
4. Bista MB, Shrestha K, Devkota UN. Gastroenteritis, Encephalits, Meningitis and Kalazar. An Epidmiology Division, Ministry of Health, Teku, Kathmandu. 1996;3-27.
5. Chatterjee BD, Braude AI, Davis CE. Infectious Disease and Medical Microbiology. 2nd ed. 1986.
6. Mhalu FS, Mmari PW, Ijumba J. Rapid emergence of EI Tor V. cholera resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania. Lancet. 1979 Feb 17;1(8112):345-7.
7. Siddique AK, Salam A, Islam MS, et al. Why treatment centers failed to prevent cholera deaths among Rwandan refugees in Goma, Zaire. Lancet. 1995;345:359-61.
8. Sunoto P. Diarrhoeal problems in Southeast Asia. Southest Asian J Trop Med Health. 1982;13(3):306-18.
9. Nair GB, Faruque SM, Bhuiyan NA, Kamruzzaman M, Siddique AK, Sack DA. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J Clin Microbiol. 2002 Sep;40(9):3296-9.
10. Salim MV. Features of Vibrio cholerae 0:1 El Tor, Inaba serotype, isolated during the cholera epidemic in Cartagena (Colombia). Enferm Infecc Microbial Clin. 1992;10(9): 525-30.
11. Shrestha CD. Outbreak of cholera in Kathmandu Valley. J Nepal Med Assoc. 1997;35:66-9.
12. Ise T, Pokhrel BM, Rawal S, Shrestha RS. Outbreak of Cholera in the Kathmandu Valley, Nepal. J Inst Med. 1994;16:196-201.
13. Malla S, Kansakar P, Ghimire G. Cholera Outbreak in Kathmandu Valley in 2004: A review of national public health laboratory findings. Journal of Nepal Association for Medical Laboratory Science. 2005;7(7):20-3.
14. Pokhrel BM, Prasai BR, Kubo T, Sharma AP, Tuladhar NR, Shrestha SP, et al. Bacteriology of diarhoea in Nepal. J Inst Med. 1997;19:128-31.
15. Gangarosa EJ, Sanati A, Saghari H, Feeley JC. Multiple serotypes of Vibrio cholerae isolated from a case of cholera. Lancet. 1967;1:646-8.
16. Stroeher UH, Karageorgos LE, Morona R, Manning PA. Serotype conversion in Vibrio cholerae O1. Proc Natl Acad Sci USA. 1992;89:2566-70.
17. Yamasaki S, Garg S, Nair GB, Takeda Y. Distribution of Vibrio cholerae O1 antigen biosynthesis genes among O139 and other non-O1 serogroups of Vibrio cholerae. FEMS Microbiol Lett. 1999;179:115-21.
18. Manning PA, Stroeher UH, Morona R. Vibrio cholerae and cholera: molecular to global perspectives. Molecular basis for O-antigen biosynthesis in Vibrio cholerae O1: Ogawa-Inaba switching. Washington, DC: ASM Press; 1994. p. 77-94.
19. Shrestha KD. Acute Diarrhoeal Cases in Nepal during Outbreak Season. An Epidemiological Review. J Nepal Med Assoc. 1995;33:219-31.
20. Kay BA, Bopp CA, Wells JG. Isolation and identification of Vibrio cholerae O1 from fecal specimens. In Vibrio cholerae and Cholera. Molecular to Global Perspectives. Washington, DC: ASM Press; 1994. p. 3-25.
21. Weber JT, Mintz ED, Canizares R, Semiglia A, Gomez I, Sempértgui R. Epidemic cholera in Ecuador: multidrug-resistance and transmission by water and seafood. Epidemiology and Infection. 1994;112:1-11.
22. Begue RE, Castellares G, Hayashi KE, Ruiz R, Oberst R. Diarrhoeal Disease in Peru after the introduction of Cholera. Amr J Trop Med. 1994;51:581-9.
23. Ramamurthy T, Pal A, Bhattacharya MK, Bhattacharya SK, Chowdhury AS, Takeda Y, et al. Serovar, biotype, phage type, toxigenicity & antibiotic susceptibility patterns of Vibrio cholerae isolated during two consecutive cholera seasons (1989-90) in Calcutta. Indian J Med Res. 1992;95:125-9.
24. Waldor MK, Tschape H, Mekalanos JJ. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. J Bacteriol. 1996;178:4157-65.
25. Burans JP, Podgore J, Mansour MM. Comparative trial of erythromycin and sulphatrimethorprim in the treatment of tetracycline-resistant Vibrio cholera 01. Trans Roy Soc Trop Med Hyg. 1989;83:836-8.